Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Menopause

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...

Infertility in Males

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...

Disorders of the Male Reproductive System

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....

Gonadal and Placental Hormones

Gonadal and Placental Hormones

The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...

Hypothalamic-Pituitary Axis

Hypothalamic-Pituitary Axis

The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.

Signs of Puberty

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Clinical Outcomes of Pathologist-Guided Ex-Vivo Onco-TESE: A Single Institution Experience and Contemporary Review.

Urology·2026

Same author

Cost Considerations of Direct to Consumer Infertility Testing and Sperm Cryopreservation.

Current urology reports·2026

Same author

Pilot study of MED3000 in treatment of erectile dysfunction after bilateral nerve-sparing radical prostatectomy.

The journal of sexual medicine·2025

Same author

Comparing remote smartphone-based semen assessments with laboratory evaluations in men unselected for fertility concerns.

Fertility and sterility·2025

Same author

Editorial Comment.

The Journal of urology·2025

Same author

Exclusion of sexual and gender minorities from erectile dysfunction clinical trials.

The journal of sexual medicine·2025

Search research articles

Related Experiment Video

Updated: Dec 29, 2025

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

(D)evolving attitudes toward late onset hypogonadism.

Martin Kathrins¹

¹Division of Urology, Brigham and Women's Hospital, Boston, Massachusetts.

Fertility and Sterility

|February 9, 2020

Summary

This summary is machine-generated.

Chemotherapy can be a useful treatment for male impotence when psychological or physical factors are the cause, though it is not a replacement for psychotherapy. This approach is indicated when these underlying issues contribute to erectile dysfunction.

More Related Videos

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

Related Experiment Videos

Last Updated: Dec 29, 2025

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

Area of Science:

Urology
Andrology
Psychiatry

Background:

Erectile dysfunction (impotence) in men can stem from psychologic or somatic (physical) causes.
Psychotherapy is a primary treatment for psychogenic impotence.

Discussion:

Chemotherapy may be indicated as an adjunct or alternative treatment when psychologic and/or somatic failures are the etiologic agents of male impotence.
The decision to use chemotherapy should consider the specific underlying causes of erectile dysfunction.

Key Insights:

Chemotherapy is a viable option for male impotence when psychological or physical factors are identified as the root cause.
It is not a standalone solution but can be effective in conjunction with other therapies.

Outlook:

Further research may explore specific chemotherapeutic agents and their efficacy in different subtypes of male impotence.
Integrating chemotherapy into treatment protocols requires careful patient selection based on etiology.